Honesty: Researchers Question Wide Use of HPV Vaccines

I (and others) have been raising red flags about Gardasil since early 2007, today the New York Times notices:

Two vaccines against cervical cancer [Gardasil by Merck Sharp & Dohme and Cervarix by GlaxoSmithKline] are being widely used without sufficient evidence about whether they are worth their high cost or even whether they will effectively stop women from getting the disease, two articles in this week’s New England Journal of Medicine conclude.

...“Despite great expectations and promising results of clinical trials, we still lack sufficient evidence of an effective vaccine against cervical cancer,” Dr. Charlotte J. Haug, editor of The Journal of the Norwegian Medical Association, wrote in an editorial in Thursday’s issue of The New England Journal. “With so many essential questions still unanswered, there is good reason to be cautious.”

Hopefully it is more evident now why I disagred with making Gardasil and Cervarix mandatory.